Offerings // Valion Bio, Inc.

VBIO offering history

Every offering-related filing in Valion Bio, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 404 filings back to Sep 10, 2019.

Last executed offering

Nov 9, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Oct 16, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Nov 9, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 27, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 21, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 20, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 20, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 16, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 8, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 8, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 1, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 24, 2026	RW →	WITHDRAWN	Registration withdrawn
Aug 17, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 12, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 6, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 17, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jun 18, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Apr 15, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 15, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 13, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Feb 9, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 20, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 20, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 16, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 16, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 29, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 29, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 12, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 12, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 11, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 6, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 17, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Sep 5, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 5, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 29, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 12, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 12, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 12, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 12, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 8, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 8, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 30, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital

VBIO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full VBIO workspace →

VBIO offering FAQ

When did VBIO last execute an offering?

Per SEC filings, Valion Bio, Inc.'s most recent priced offering document is a 8-K filed 2026-11-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did VBIO last announce or register an offering?

The most recent registration is a S-3 filed 2026-10-16. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.